Volitionrx Limited (VNRX) Misses Q2 EPS by 1c

Volitionrx Limited (NYSE: VNRX) reported Q2 EPS of ($0.13), $0.01 worse than the analyst estimate of ($0.12).

For earnings history and earnings-related data on Volitionrx Limited (VNRX) click here.

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• Accenture (ACN) Tops Q3 EPS by 8c, Misses on Revenue; Offers FY26 EPS Guidance
• VolitionRx and Sysmex partner to optimize NETs diagnostic assay